Scout | Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)

The Avenir Award Program supports early stage investigators conducting innovative research on substance abuse and HIV/AIDS. It targets studies that align with NIH HIV/AIDS research priorities, focusing on the connection between drug abuse and HIV/AIDS. The program funds both basic and clinical research that could reduce HIV incidence, improve HIV therapies, mitigate comorbid conditions, and ai…

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Dates

Opportunity Released: March 10, 2023

Open for Submission: March 10, 2023

Submission Deadline: August 15, 2025

Application Window Closes: August 15, 2025

Keywords

Avenir Award

Substance Abuse

HIV/AIDS

Early Stage Investigators

NIH Research Priorities

Innovative Studies

Drug Abuse Nexus

HIV Incidence Reduction

Clinical Research

Comorbid Conditions.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers